N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide

C98H88Br4N16O8 — CID 157426208

IUPACN-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide
SMILESCCN1CCN=C1c1ccc(C(=O)Cc2ccccc2C(=O)Nc2ccc(Br)cn2)cc1.CN1CCCN=C1c1ccc(C(=O)Cc2ccccc2C(=O)Nc2ccc(Br)cn2)cc1.CN1CCN=C1c1ccc(C(=O)Cc2ccccc2C(=O)Nc2ccc(Br)cn2)cc1.O=C(Cc1ccccc1C(=O)Nc1ccc(Br)cn1)c1ccc(C2=NCCCN2)cc1
InChIInChI=1S/2C25H23BrN4O2.2C24H21BrN4O2/c1-30-14-4-13-27-24(30)18-9-7-17(8-10-18)22(31)15-19-5-2-3-6-21(19)25(32)29-23-12-11-20(26)16-28-23;1-2-30-14-13-27-24(30)18-9-7-17(8-10-18)22(31)15-19-5-3-4-6-21(19)25(32)29-23-12-11-20(26)16-28-23;1-29-13-12-26-23(29)17-8-6-16(7-9-17)21(30)14-18-4-2-3-5-20(18)24(31)28-22-11-10-19(25)15-27-22;25-19-10-11-22(28-15-19)29-24(31)20-5-2-1-4-18(20)14-21(30)16-6-8-17(9-7-16)23-26-12-3-13-27-23/h2-3,5-12,16H,4,13-15H2,1H3,(H,28,29,32);3-12,16H,2,13-15H2,1H3,(H,28,29,32);2-11,15H,12-14H2,1H3,(H,27,28,31);1-2,4-11,15H,3,12-14H2,(H,26,27)(H,28,29,31)
InChIKeyBPZIOSSXKMWTTL-UHFFFAOYSA-N
MW1937.50 g/mol
LogP17.68
Rot. Bonds25

About N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide

N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide (PubChem CID 157426208) has the molecular formula C98H88Br4N16O8 and a molecular weight of 1937.50 g/mol. Its IUPAC name is N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide.

Molecular Properties

Compound NameN-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide
PubChem CID157426208
Molecular FormulaC98H88Br4N16O8
Molecular Weight1937.50 g/mol
Exact Mass1932.37
IUPAC NameN-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide
SMILESCCN1CCN=C1c1ccc(C(=O)Cc2ccccc2C(=O)Nc2ccc(Br)cn2)cc1.CN1CCCN=C1c1ccc(C(=O)Cc2ccccc2C(=O)Nc2ccc(Br)cn2)cc1.CN1CCN=C1c1ccc(C(=O)Cc2ccccc2C(=O)Nc2ccc(Br)cn2)cc1.O=C(Cc1ccccc1C(=O)Nc1ccc(Br)cn1)c1ccc(C2=NCCCN2)cc1
InChIInChI=1S/2C25H23BrN4O2.2C24H21BrN4O2/c1-30-14-4-13-27-24(30)18-9-7-17(8-10-18)22(31)15-19-5-2-3-6-21(19)25(32)29-23-12-11-20(26)16-28-23;1-2-30-14-13-27-24(30)18-9-7-17(8-10-18)22(31)15-19-5-3-4-6-21(19)25(32)29-23-12-11-20(26)16-28-23;1-29-13-12-26-23(29)17-8-6-16(7-9-17)21(30)14-18-4-2-3-5-20(18)24(31)28-22-11-10-19(25)15-27-22;25-19-10-11-22(28-15-19)29-24(31)20-5-2-1-4-18(20)14-21(30)16-6-8-17(9-7-16)23-26-12-3-13-27-23/h2-3,5-12,16H,4,13-15H2,1H3,(H,28,29,32);3-12,16H,2,13-15H2,1H3,(H,28,29,32);2-11,15H,12-14H2,1H3,(H,27,28,31);1-2,4-11,15H,3,12-14H2,(H,26,27)(H,28,29,31)
InChIKeyBPZIOSSXKMWTTL-UHFFFAOYSA-N
XLogP17.68
TPSA307.43 Ų
H-Bond Donors5
H-Bond Acceptors20
Rotatable Bonds25
Heavy Atoms126
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001937.50
LogP ≤ 517.68
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1020

Analyze N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(5-bromo-2-pyridinyl)-2-[2-[2-fluoro-4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]-5-methylbenzamide
CID 59585415
N-(5-bromo-2-pyridinyl)-2-[2-[2-fluoro-4-(piperidine-1-carboximidoyl)phenyl]-2-oxoethyl]benzamide
CID 59585477
N-(5-bromo-2-pyridinyl)-2-[2-[2-fluoro-4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide
CID 59585485
N-(5-bromo-2-pyridinyl)-2-[2-[2-fluoro-4-(piperidine-1-carboximidoyl)phenyl]-2-oxoethyl]-5-methylbenzamide
CID 59585490
N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]-5-(trifluoromethyl)benzamide
CID 159306635
N-(5-bromo-2-pyridinyl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-4,5-dimethylbenzamide;N-(5-bromo-2-pyridinyl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-(trifluoromethyl)benzamide;N-(5-bromo-2-pyridinyl)-4,5-dimethyl-2-[[4-(1-methyl-4,5-dihydroimidazol-2-yl)benzoyl]amino]benzamide;N-(5-bromo-2-pyridinyl)-2-[[4-(1-methyl-4,5-dihydroimidazol-2-yl)benzoyl]amino]-5-(trifluoromethyl)benzamide
CID 160669517
N-(5-bromo-2-pyridinyl)-4,5-difluoro-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide
CID 158651977
N-(5-bromo-2-pyridinyl)-4,5-difluoro-2-[2-oxo-2-[4-(piperidine-1-carboximidoyl)phenyl]ethyl]benzamide
CID 158763103
N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide
CID 59089733
N-(5-bromo-2-pyridinyl)-2-[2-[4-(N,N-dimethylcarbamimidoyl)phenyl]-2-oxoethyl]benzamide
CID 59585419
N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(piperidine-1-carboximidoyl)phenyl]ethyl]benzamide
CID 59585444
N-(5-bromo-2-pyridinyl)-2-[2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-2-oxoethyl]benzamide
CID 59585448

Frequently Asked Questions

What is the IUPAC name of N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide?
The IUPAC name of N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide (CID 157426208) is N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide.
What is the SMILES notation for N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide?
The canonical SMILES for N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide is CCN1CCN=C1c1ccc(C(=O)Cc2ccccc2C(=O)Nc2ccc(Br)cn2)cc1.CN1CCCN=C1c1ccc(C(=O)Cc2ccccc2C(=O)Nc2ccc(Br)cn2)cc1.CN1CCN=C1c1ccc(C(=O)Cc2ccccc2C(=O)Nc2ccc(Br)cn2)cc1.O=C(Cc1ccccc1C(=O)Nc1ccc(Br)cn1)c1ccc(C2=NCCCN2)cc1.
What is the InChIKey of N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide?
The InChIKey is BPZIOSSXKMWTTL-UHFFFAOYSA-N. The full InChI is InChI=1S/2C25H23BrN4O2.2C24H21BrN4O2/c1-30-14-4-13-27-24(30)18-9-7-17(8-10-18)22(31)15-19-5-2-3-6-21(19)25(32)29-23-12-11-20(26)16-28-23;1-2-30-14-13-27-24(30)18-9-7-17(8-10-18)22(31)15-19-5-3-4-6-21(19)25(32)29-23-12-11-20(26)16-28-23;1-29-13-12-26-23(29)17-8-6-16(7-9-17)21(30)14-18-4-2-3-5-20(18)24(31)28-22-11-10-19(25)15-27-22;25-19-10-11-22(28-15-19)29-24(31)20-5-2-1-4-18(20)14-21(30)16-6-8-17(9-7-16)23-26-12-3-13-27-23/h2-3,5-12,16H,4,13-15H2,1H3,(H,28,29,32);3-12,16H,2,13-15H2,1H3,(H,28,29,32);2-11,15H,12-14H2,1H3,(H,27,28,31);1-2,4-11,15H,3,12-14H2,(H,26,27)(H,28,29,31).
What are the key properties of N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide?
N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide has a molecular weight of 1937.50 g/mol, XLogP of 17.68, 25 rotatable bonds, 5 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-ethyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-4,5-dihydroimidazol-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-[4-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)phenyl]-2-oxoethyl]benzamide;N-(5-bromo-2-pyridinyl)-2-[2-oxo-2-[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]ethyl]benzamide is sourced from PubChem (CID 157426208), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).